Juventas Therapeutics Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
15
Juventas Therapeutics General Information
Description
Developer of regenerative therapies intended to treat cardiovascular diseases and ischemic disorders. The company's therapies include non-viral gene therapy which can activate natural processes to repair the body, enabling patients to begin treatment promptly and resulting in a likelihood of successful treatment.
Contact Information
Website
www.juventasinc.comCorporate Office
- 3615 Superior Avenue
- Suite 4403B
- Cleveland, OH 44114
- United States
Corporate Office
- 3615 Superior Avenue
- Suite 4403B
- Cleveland, OH 44114
- United States
Juventas Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 04-Oct-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B2) | 07-May-2015 | Completed | Clinical Trials - Phase 2 | |||
| 5. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 4. Later Stage VC (Series B1) | 20-Nov-2013 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series B) | 16-Jul-2012 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 09-Oct-2008 | $6.9M | $10M | Completed | Startup | |
| 1. Early Stage VC | 30-Jul-2007 | $3.1M | $3.1M | Completed | Startup |
Juventas Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B | 15,000,001 | $0.010000 | $1.5 | $1.5 | 1x | $1.5 | 39.24% | |
| Series A | 6,139,280 | $0.010000 | $1.31 | $1.31 | 1x | $1.31 | 16.06% |
Juventas Therapeutics Comparisons
Industry
Financing
Details
Juventas Therapeutics Competitors (61)
One of Juventas Therapeutics’s 61 competitors is Ability Pharma, a Private Equity-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ability Pharma | Private Equity-Backed | Barcelona, Spain | ||||
| Neurona Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| Lineage Cell Therapeutics | Corporation | Carlsbad, CA | ||||
| Jaguar Gene Therapy | Venture Capital-Backed | Lake Forest, IL |
Juventas Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Juventas Therapeutics Patents
Juventas Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170049856-A1 | Sdf-1 delivery for treating advanced ischemic cardiomyopathy | Inactive | 28-Apr-2014 | ||
| US-20160024521-A1 | Retrograde delivery of sdf-1 for treatment of myocardial infarction | Inactive | 15-Mar-2013 | ||
| EP-2968608-A2 | Retrograde delivery of sdf-1 for treatment of myocardial infarction | Inactive | 15-Mar-2013 | ||
| CA-2904540-A1 | Retrograde delivery of sdf-1 for treatment of myocardial infarction | Inactive | 15-Mar-2013 | ||
| EP-2970941-A1 | Sdf-1 delivery for treating ischemic tissue | Inactive | 15-Mar-2013 | C07K14/522 |
Juventas Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Juventas Therapeutics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GC Biopharma | Corporation | Minority | ||
| Gradus Life Sciences | Corporate Venture Capital | Minority | ||
| Posco Investment | Corporate Venture Capital | Minority | ||
| RSJ Investments | PE/Buyout | Minority | ||
| Cleveland Clinic Ventures | Corporate Venture Capital | Minority |
Juventas Therapeutics FAQs
-
When was Juventas Therapeutics founded?
Juventas Therapeutics was founded in 2007.
-
Where is Juventas Therapeutics headquartered?
Juventas Therapeutics is headquartered in Cleveland, OH.
-
What is the size of Juventas Therapeutics?
Juventas Therapeutics has 4 total employees.
-
What industry is Juventas Therapeutics in?
Juventas Therapeutics’s primary industry is Drug Discovery.
-
Is Juventas Therapeutics a private or public company?
Juventas Therapeutics is a Private company.
-
What is Juventas Therapeutics’s current revenue?
The current revenue for Juventas Therapeutics is .
-
How much funding has Juventas Therapeutics raised over time?
Juventas Therapeutics has raised $51.9M.
-
Who are Juventas Therapeutics’s investors?
GC Biopharma, Gradus Life Sciences, Posco Investment, RSJ Investments, and Cleveland Clinic Ventures are 5 of 15 investors who have invested in Juventas Therapeutics.
-
Who are Juventas Therapeutics’s competitors?
Ability Pharma, Neurona Therapeutics, CervoMed, Lineage Cell Therapeutics, and Jaguar Gene Therapy are some of the 61 competitors of Juventas Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
